Osteoarthritis Injectables Market Size, Share, Trends, Growth Outlook

Global Osteoarthritis Injectables Market size of $4.4 Billion in 2024 and is forecast to register a growth rate (CAGR) of 6.9% to reach $7.5 Billion by 2032.

The global Osteoarthritis Injectables Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Acetylsalicylic Acid (ASA) Injections, Others), By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Others), By End-User (Hospital Pharmacies, Retail Pharmacies, Others).

Osteoarthritis Injectables Market Competitive Landscape

The market report analyses the leading companies in the industry including Anika Therapeutics Inc, Arthrex Inc, Bioventus, Ferring Pharmaceuticals Inc, Flexion Therapeutics Inc, Royal Biologics, Sanofi S.A., Teva Pharmaceutical Industries Ltd, Zimmer Biomet, and others.

Osteoarthritis Injectables Market Dynamics

Market Trend: Increasing Use of Hyaluronic Acid and Platelet-Rich Plasma Injections

The Osteoarthritis Injectables Market is witnessing a prominent trend with the increasing use of hyaluronic acid and platelet-rich plasma (PRP) injections. These injectables are gaining popularity due to their effectiveness in reducing pain and improving joint function. Hyaluronic acid provides lubrication and cushioning in the joint, while PRP leverages the body's natural healing processes, making them preferred options among patients and healthcare providers.

Market Driver: Rising Prevalence of Osteoarthritis and Aging Population

A key driver for the Osteoarthritis Injectables Market is the rising prevalence of osteoarthritis, particularly among the aging population. As the global population ages, the incidence of osteoarthritis is increasing, leading to a higher demand for effective treatment options. This demographic shift is driving the growth of the market as more individuals seek non-surgical solutions to manage their symptoms and improve their quality of life.

Market Opportunity: Development of Novel Biologic Therapies

The potential opportunity for the Osteoarthritis Injectables Market lies in the development of novel biologic therapies. Advances in biotechnology are paving the way for new injectable treatments that target the underlying causes of osteoarthritis rather than just alleviating symptoms. Companies that invest in research and development to create innovative biologic injectables can capture significant market share by offering advanced solutions that provide longer-lasting relief and potentially alter the disease progression.

Osteoarthritis Injectables Market Share Analysis: Hyaluronic Acid Injections is the Largest Segment by Type

The largest segment in the Osteoarthritis Injectables Market by type is Hyaluronic Acid Injections. These injections are extensively used to manage osteoarthritis symptoms, particularly in the knee. They work by mimicking the natural synovial fluid, providing lubrication and cushioning to the joint, which can reduce pain and improve mobility. The widespread adoption of hyaluronic acid injections is driven by their effectiveness, minimal side effects, and the growing preference for non-surgical treatment options among osteoarthritis patients.

Osteoarthritis Injectables Market Share Analysis: Knee Osteoarthritis is the Fastest Growing Segment by Anatomy

Knee Osteoarthritis is poised to register the fastest growth (CAGR) over the forecast period to 2030. This rapid growth can be attributed to the high prevalence of knee osteoarthritis, which is a major cause of disability among the elderly. Advances in medical research and the development of new injectable treatments specifically targeting knee joints have increased the efficacy and popularity of these treatments. Additionally, increasing awareness about the benefits of early intervention and the rising incidence of obesity, which is a risk factor for knee osteoarthritis, are contributing to the fast growth of this segment.

Osteoarthritis Injectables Market Share Analysis: Hospital Pharmacies is the Largest Segment by End-User

The largest segment in the Osteoarthritis Injectables Market by end-user is Hospital Pharmacies. Hospital pharmacies are pivotal in the distribution of osteoarthritis injectables due to their accessibility and the comprehensive care they provide. Hospitals often serve as the primary point of treatment for osteoarthritis patients, where they receive diagnosis, treatment plans, and follow-up care. The centralized nature of hospitals ensures that they are the main distributors of these injectables, reinforcing their position as the largest segment by end-user.

Osteoarthritis Injectables Market Report Segmentation

By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Osteoarthritis Injectables Market Companies Profiled in the Study

Anika Therapeutics Inc
Arthrex Inc
Bioventus
Ferring Pharmaceuticals Inc
Flexion Therapeutics Inc
Royal Biologics
Sanofi S.A.
Teva Pharmaceutical Industries Ltd
Zimmer Biomet
*- List Not Exhaustive

TABLE OF CONTENTS

1 Introduction to 2024 Osteoarthritis Injectables Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Osteoarthritis Injectables Market Size Outlook, $ Million, 2021 to 2032
3.2 Osteoarthritis Injectables Market Outlook by Type, $ Million, 2021 to 2032
3.3 Osteoarthritis Injectables Market Outlook by Product, $ Million, 2021 to 2032
3.4 Osteoarthritis Injectables Market Outlook by Application, $ Million, 2021 to 2032
3.5 Osteoarthritis Injectables Market Outlook by Key Countries, $ Million, 2021 to 2032

4 Market Dynamics
4.1 Key Driving Forces of Osteoarthritis Injectables Industry
4.2 Key Market Trends in Osteoarthritis Injectables Industry
4.3 Potential Opportunities in Osteoarthritis Injectables Industry
4.4 Key Challenges in Osteoarthritis Injectables Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Osteoarthritis Injectables Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Osteoarthritis Injectables Market Outlook by Segments
7.1 Osteoarthritis Injectables Market Outlook by Segments, $ Million, 2021- 2032
By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others

8 North America Osteoarthritis Injectables Market Analysis and Outlook To 2032
8.1 Introduction to North America Osteoarthritis Injectables Markets in 2024
8.2 North America Osteoarthritis Injectables Market Size Outlook by Country, 2021-2032
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Osteoarthritis Injectables Market size Outlook by Segments, 2021-2032
By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others

9 Europe Osteoarthritis Injectables Market Analysis and Outlook To 2032
9.1 Introduction to Europe Osteoarthritis Injectables Markets in 2024
9.2 Europe Osteoarthritis Injectables Market Size Outlook by Country, 2021-2032
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Osteoarthritis Injectables Market Size Outlook by Segments, 2021-2032
By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others

10 Asia Pacific Osteoarthritis Injectables Market Analysis and Outlook To 2032
10.1 Introduction to Asia Pacific Osteoarthritis Injectables Markets in 2024
10.2 Asia Pacific Osteoarthritis Injectables Market Size Outlook by Country, 2021-2032
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Osteoarthritis Injectables Market size Outlook by Segments, 2021-2032
By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others

11 South America Osteoarthritis Injectables Market Analysis and Outlook To 2032
11.1 Introduction to South America Osteoarthritis Injectables Markets in 2024
11.2 South America Osteoarthritis Injectables Market Size Outlook by Country, 2021-2032
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Osteoarthritis Injectables Market size Outlook by Segments, 2021-2032
By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others

12 Middle East and Africa Osteoarthritis Injectables Market Analysis and Outlook To 2032
12.1 Introduction to Middle East and Africa Osteoarthritis Injectables Markets in 2024
12.2 Middle East and Africa Osteoarthritis Injectables Market Size Outlook by Country, 2021-2032
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Osteoarthritis Injectables Market size Outlook by Segments, 2021-2032
By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
Anika Therapeutics Inc
Arthrex Inc
Bioventus
Ferring Pharmaceuticals Inc
Flexion Therapeutics Inc
Royal Biologics
Sanofi S.A.
Teva Pharmaceutical Industries Ltd
Zimmer Biomet

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Hyaluronic Acid Injections
Corticosteroid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Others
By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)